TITLE

Organizations add input on IC with biospecimens

PUB. DATE
November 2011
SOURCE
Clinical Trials Administrator;Nov2011, Vol. 9 Issue 11, p127
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article states that national research organizations and individual researchers are urging the government to reconsider their plans regarding informed consent for biospecimens. It mentions the options suggested by the Mayo Clinic of Rochester for consideration by the Department of Health and Human Services (HHS). Included are comments from Helen P. Cathro, an associate professor at the University of Virginia, who wrote a personal comment to the Office for Human Research Protections (OHRP).
ACCESSION #
67247581

 

Related Articles

  • Common Rule tissue changes elicit objections.  // Clinical Trials Administrator;Nov2011, Vol. 9 Issue 11, p125 

    The article offers information on the proposed change to the research Common Rule regarding the strengthening of informed consent protections related to research involving biospecimens. It discusses whether such rules may lead to collateral damage to the research enterprise. Included are...

  • CNE/CME QUESTIONS.  // Clinical Trials Administrator;Nov2011, Vol. 9 Issue 11, p131 

    A continuing nursing education (CNE) quiz concerning various topics pertaining to disaster preparedness in clinical research, proposed changes to the Common Rule on research using biospecimens, and proper signing and dating of informed consent (IC) forms, is presented.

  • CNE/CME QUESTIONS.  // IRB Advisor;Oct2011, Vol. 11 Issue 10, p108 

    A quiz related to the topics discussed within the journal, including proposed Common Rule changes for institutional review boards (IRBs) and biobanks, is presented.

  • The Informed Consent Process. Odeh, Peter // AMT Events;Mar2013, Vol. 30 Issue 1, p24 

    No abstract available.

  • Michigan BioTrust consent options.  // IRB Advisor;Jun2013, Vol. 13 Issue 6, p66 

    The article discusses the bio repository of dried blood spots following newborn screening at the Michigan BioTrust for Health, U.S., however it is now that the agency intends to use de-identified samples for research based on prior informed consent.

  • Avoiding little mistakes-- and bigger problems.  // Clinical Trials Administrator;Oct2010, Vol. 8 Issue 10, p115 

    The article presents tips on preventing minor errors in clinical research documentation that could assist in solving major research problems. It stresses the importance of documenting the date with a stamp when the document is received from the institutional review board (IRB). Online sites are...

  • Expert tips on preventing persistent IC problems.  // IRB Advisor;Nov2011, Vol. 11 Issue 11, p118 

    The article presents questions and answers pertaining to the chief problems with the informed consent (IC) documentation and the ways in which those can be prevented.

  • IC experts advocate improvements to process.  // IRB Advisor;Dec2011, Vol. 11 Issue 12, p126 

    No abstract available.

  • Letter to the Editor. Shu Yu Chen // Nursing Ethics;11/01/2010, Vol. 17 Issue 6, p791 

    A letter to the editor is presented in response to the article "Informed consent practices of Chinese nurse researcher," by Douglas P. Olsen, H. Wang, and S. Pang in the 2010 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics